Natera, Inc. (NTRA) shares fell 1.6% to $345.34 as of September 17, 2026, a modest decline from the prior close of $350.78. BestStocks flagged the session as a major change for NTRA. Below, we break down what changed for NTRA, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
What happened
NTRA fell 1.6% to $345.34
NTRA fell 1.6% in its latest session, moving from $350.78 to $345.34.
ValuationLow confidence
Rel. volume
1.0×
Below Avg
Vs peers
—
No comparable peers
Market cap
$49.5B
NASDAQ Global Select
Analyst target
$335
-3.0% vs price
Price chart
Aug 17 – Sep 17
E earnings
F filing
A analyst
V/N other
click a marker to highlight
Change events — click to jump to details
What it means for Natera, Inc. investors
For Natera, Inc. investors, the recent signals add up to a bearish shift. On the constructive side: Natera surged +20.58% to $320.00 following a strong Q2 2026 earnings beat released after market close on August 6; Natera, Inc. (NTRA) moved +2.72% from $274.39 to $281.85 on 2026-07-09. Weighing against that: Material negative event; Negative session, down 1.6%. Wall Street's consensus price target sits at $335.07, implying -3.0% downside from $345.34. BestStocks rates the overall signal quality low (41/100). With earnings roughly 49 days out, the next report is the most likely near-term test of the move.
NTRA price reaction
NTRA last traded at $345.34, down $5.44 (-1.55%) from the previous close of $350.78. The session traded on 1.0× average volume (below avg), so participation was unremarkable. Over the past month the stock has ranged between $311.69 and $350.78, and it currently sits about 86% of the way up that band.
Bullish and bearish analyst opinions on Natera, Inc. (NTRA)
The consensus analyst price target on Natera, Inc. (NTRA) is $335.07, 3.0% below the recent $345.34. Over the past 90 days analysts logged 0 upgrades, 19 maintains, and 0 downgrades. Here is how the bullish and bearish cases on NTRA line up.
▲ The bullish case
+The Street's most bullish target is $435.00 (+26.0%).
+Natera surged +20.58% to $320.00 following a strong Q2 2026 earnings beat released after market close on August 6.
+Natera, Inc. (NTRA) moved +2.72% from $274.39 to $281.85 on 2026-07-09.
+Positive price momentum.
▼ The bearish case
−The consensus analyst price target of $335.07 sits 3.0% below the recent $345.34, so the average target sees limited room to run.
−The most bearish analyst target is $245.00 (-29.1%).
−Material negative event.
−Negative session, down 1.6%.
−Natera, Inc. (NTRA) moved −3.23% from $271.39 to $262.63 on 2026-07-20.
Bull vs bear balanceBearish Shift
BearishNeutralBullish
Weighing both sides, BestStocks' composite read of recent signals is bearish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Sep 17, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Natera, Inc. (NTRA) moved +4.23% from $327.91 to $341.79 on 2026-09-14, reaching a new 30-day high. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume remained near its 5-day average.
Material / Earnings2026-08-28-3.7%
Natera, Inc. (NTRA) moved -2.69% from $335.28 to $326.26 on 2026-08-28. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume was near its 5-day average, indicating routine trading.
Natera shares rose 1.83% to $333.72 following Japan's Pharmaceuticals and Medical Devices Agency approval of its Signatera molecular residual disease test for colorectal cancer patients, marking the first such approved test in Japan with commercial launch planned by end-2026. Volume traded 3.60x the time-adjusted expected level, signaling elevated investor interest. The move extends recent momentum after BTIG analysts raised their price target to $270 on Signatera's inclusion in NCCN guidelines for muscle-invasive bladder cancer.
Material / Earnings2026-08-21+2.2%
Natera, Inc. (NTRA) moved +2.16% from $325.00 to $332.03 on 2026-08-21, reaching a new 30-day high. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. The move appears to be technical, with the stock reaching its highest level in 30 days on volume near its 5-day average.
Natera surged +20.58% to $320.00 following a strong Q2 2026 earnings beat released after market close on August 6. The company reported revenue of $752.8 million, 37.7% YoY growth and well above the ~$661M consensus estimate, while narrowing its GAAP loss to $0.47 per share. Management raised full-year 2026 guidance to $2.85–$2.91B from $2.74–$2.82B, citing record test volumes of 1.04M (56% YoY growth in Signatera MRD units). Volume stands at 2.17M shares, 2.72x the time-adjusted average.
Filings2026-08-07+21.4%
Natera, Inc. (NTRA) filed its 10-Q on 2026-08-07, disclosing financial results for the most recent quarter.
Material / Earnings2026-08-06-3.4%
Natera, Inc. (NTRA) reported EPS of –$0.47 vs. –$0.49 consensus estimate, beating by 4.8% on 2026-08-06.
Material / Earnings2026-07-31-0.7%
Natera, Inc. (NTRA) moved -2.63% from $275.00 to $267.76 on 2026-07-31. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume was 1.4x the 5-day average, modestly elevated.
In-depth NTRA event analyses
Permanent, dated analyses of NTRA's most significant sessions.
NTRA fell 1.6% to $345.34. No single company-specific catalyst was confirmed during the move window, and it looks technical.
How much did NTRA stock fall?
NTRA lost 1.55% ($5.44) versus the prior close of $350.78, last trading at $345.34 on 1.0× average volume.
When is Natera, Inc.'s next earnings date?
NTRA's next earnings report is estimated for 2026-11-05 — about 49 days away.
What is the analyst price target for NTRA?
The consensus analyst price target for NTRA is $335.07, about 3.0% below the current $345.34. Over the past 90 days, analysts recorded 0 upgrades, 19 maintains, and 0 downgrades.
How BestStocks tracks NTRA
This page is generated automatically by BestStocks' change-detection system after its price and volume cleared NTRA-specific materiality thresholds, triggering an evidence check. It draws on 20 tracked change events for NTRA, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of September 17, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.
